Novartis Ireland Limited (Novartis Ireland Limited)

Lobbying Organisation Novartis Ireland Limited

Date published 14 May, 2026

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan. 2026 to 30 Apr. 2026

Specific Details Roundtable policy meeting to discuss EU and Irish Cardiovascular Strategy

Intended results To support policy makers to develop a National Cardiovascular Strategy in the context of the European Commission's Safe Hearts Plan and call to action for all member states.

Name of person primarily responsible for lobbying on this activity Eibhlín Mulroe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

A roundtable discussion facilitated in Dublin's Alex Hotel supported by Red Flag. Held on the 25th February 2026 between politicians and stakeholders; including clinicians and patient advocates.

Email (6-10)

Email submissions to discussion from those not in attendance for white paper.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Martin Daly TD (Dáil Éireann, the Oireachtas)

Tom Clonan Senator (Seanad)

Colm Burke TD (Dáil Éireann, the Oireachtas)

David Cullinane TD (Dáil Éireann, the Oireachtas)

Marie Sherlock TD (Dáil Éireann, the Oireachtas)